APA (7th ed.) Citation

M, P., L, K., E, H., L, B., M, G., S, N., . . . J, T. (2020). Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative ≤ T1b Breast Cancer. Annals of surgical oncology, 27(5), 1671. https://doi.org/10.1245/s10434-019-08028-w

Chicago Style (17th ed.) Citation

M, Pomponio, Keele L, Hilt E, Burkbauer L, Goldbach M, Nazarian S, Fox K, and Tchou J. "Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative ≤ T1b Breast Cancer." Annals of Surgical Oncology 27, no. 5 (2020): 1671. https://doi.org/10.1245/s10434-019-08028-w.

MLA (9th ed.) Citation

M, Pomponio, et al. "Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative ≤ T1b Breast Cancer." Annals of Surgical Oncology, vol. 27, no. 5, 2020, p. 1671, https://doi.org/10.1245/s10434-019-08028-w.